Clinical trial
Gamma Interferon Therapy for Chronic Hepatitis C
NCT00028275 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00028275 |
|---|---|
| Title | Gamma Interferon Therapy for Chronic Hepatitis C |
| Official title | Pilot Studies of Gamma Interferon Therapy for Chronic Hepatitis C |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Gamma Interferon 1b |
| Enrollment | 20 |
| Start date | Dec 1, 2001 |
| Completion | Nov 1, 2003 |
| First posted | Dec 19, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: